Related Experiment Video
Updated: Jun 10, 2026
MR Molecular Imaging of Prostate Cancer with a Small Molecular CLT1 Peptide Targeted Contrast Agent
Published on: September 3, 2013
[Molecular imaging in cancer therapy]
1Nuklearmedizinische Klinik, Universitätsklinikum Freiburg, Deutschland. wolfgang.weber@uniklinik-freiburg.de
Abstract:
Targeted drugs that modulate the function of specific molecules in diseased tissues hold great promise for the treatment of many diseases, including malignant tumors. However, there are several challenges for the efficient evaluation of these drugs in clinical trials as well as for the use in clinical practice. These include (i) the selection of patients likely to benefit from treatment with a specific targeted drug, (ii) finding the right dose and dose schedule, (iii) monitoring target inhibition, and (iv) assessing tumor response to therapy. Standard anatomic imaging continues to play an important role for addressing these challenges, but molecular imaging provides several new opportunities to make the use of targeted drugs more efficient. Using molecular imaging, the expression of drug targets can be assessed noninvasively, the concentration of drugs can be measured in the tumor tissue, target inhibition can be monitored, and tumor response to therapy can be evaluated earlier than with anatomic imaging techniques. Therefore, it is expected that molecular imaging will play an increasing role for guiding molecularly defined therapeutic interventions.
Insights
Molecular imaging enhances targeted drug therapy by enabling noninvasive assessment of drug targets and treatment response. This approach optimizes patient selection, dosing, and monitoring for improved clinical trial efficiency and patient outcomes.
Area of Science:
- Oncology
- Pharmacology
- Medical Imaging
Context:
- Targeted drugs offer promise for treating diseases like cancer but face challenges in clinical evaluation and practice.
- Efficiently using targeted therapies requires patient selection, optimal dosing, target inhibition monitoring, and response assessment.
Purpose:
- To explore the role of molecular imaging in overcoming challenges associated with targeted drug therapy.
- To highlight how molecular imaging can improve the efficiency of targeted drug evaluation and clinical application.
Summary:
- Molecular imaging allows noninvasive assessment of drug target expression and drug concentration within tumor tissues.
- It enables real-time monitoring of target inhibition and earlier evaluation of tumor response to therapy compared to standard methods.
- These capabilities facilitate more efficient and personalized use of targeted drugs in clinical settings.
Impact:
- Molecular imaging is expected to play a crucial role in guiding molecularly defined therapeutic interventions.
- It promises to enhance the precision and effectiveness of targeted cancer treatments.
- This technology can lead to better patient stratification and treatment efficacy monitoring in clinical trials and practice.
More Related Videos
06:51Utilizing 18F-FDG PET/CT Imaging and Quantitative Histology to Measure Dynamic Changes in the Glucose Metabolism in Mouse Models of Lung Cancer
Published on: July 21, 2018
10:04Radionuclide-fluorescence Reporter Gene Imaging to Track Tumor Progression in Rodent Tumor Models
Published on: March 13, 2018
Related Concept Videos
02:57Targeted Cancer Therapies
There are several types of targeted therapies against specific...
01:25Imaging Studies II: Positron Emission Tomography and Scintigraphy
Fundamental Principles of PET